Back to mobile site
Get it on Google Play

Mylan Laboratories (MYL) Receives FDA Approval for Sumatriptan Succinate Tablets

May 24, 2006 9:20 AM EDT Send to a Friend
Mylan Laboratories Inc. (NYSE: MYL) announced that the U.S. Food and Drug Administration has granted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login